Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
about
Biomarkers in heart failure with preserved ejection fractionEpidemiology of left ventricular hypertrophy in hypertension: implications for the clinic.Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis).Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Invited Commentary: Searching for the Perfect Measure of Diastolic Dysfunction-A Futile Exercise?Troponin in Cardiovascular Disease Prevention: Updates and Future Direction.Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction."Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).Dynamic Changes in High-Sensitivity Cardiac Troponin I Are Associated with Dynamic Changes in Sum Absolute QRST Integral on Surface Electrocardiogram in Acute Decompensated Heart Failure.Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers.
P2860
Q26768192-0C1A4C5F-5D9F-4CD6-975C-84D73304F51EQ30250365-99BB8B93-9B5E-48D2-844A-3C4381097920Q37207790-1FAADAB9-4D12-48AD-84D3-571DF668E18AQ38614176-042398E2-403C-473D-BB27-16F66A215428Q38689757-D28DD34D-FCAB-46D5-8004-ED66FD1CAB19Q38734398-BF566AA8-0298-4AEB-8812-A60BAC626BC4Q38762394-B9D164F4-D1CD-4227-8CC1-551215F9C49BQ38780602-10365675-E622-4950-A626-293478856600Q38838027-4150CACA-B143-4CB8-905B-2F85226B7763Q39579918-465263DD-80C5-4796-B021-4930183020CDQ47739211-6F552DA0-697F-40AA-BB4B-8B7AB3ACDC89Q50044397-868D6209-9050-4810-AC7E-CBDFD4223FEDQ50890696-00732A2E-AC29-46E0-A8AE-7B7664B396B1Q55343200-A71BC918-1630-4CCF-9DAB-8EFA47FED064
P2860
Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Older Adults, "Malignant" Left ...... (Cardiovascular Health Study).
@ast
Older Adults, "Malignant" Left ...... (Cardiovascular Health Study).
@en
type
label
Older Adults, "Malignant" Left ...... (Cardiovascular Health Study).
@ast
Older Adults, "Malignant" Left ...... (Cardiovascular Health Study).
@en
prefLabel
Older Adults, "Malignant" Left ...... (Cardiovascular Health Study).
@ast
Older Adults, "Malignant" Left ...... (Cardiovascular Health Study).
@en
P2093
P2860
P1433
P1476
Older Adults, "Malignant" Left ...... (Cardiovascular Health Study).
@en
P2093
Christopher deFilippi
Ian J Neeland
James de Lemos
Jarett Berry
John Gottdiener
John Sorkin
Mark H Drazner
Robert Christenson
Stephen L Seliger
P2860
P304
P356
10.1016/J.JCHF.2014.12.018
P577
2015-05-14T00:00:00Z